SEARCH

SEARCH BY CITATION

References

  • AISAKA, K., GROSS, S.S., GRIFFITH, O.W. & LEVI, R. (1989a). NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea-pig: does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun., 160, 881886.
  • AISAKA, K., GROSS, S.S., GRIFFITH, O.W. & LEVI, R. (1989b). l-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochem. Biophys. Res. Commun., 163, 710717.
  • AMEZCUA, J.L., DUSTING, G.J., PALMER, R.M.J. & MONCADA, S. (1988). Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. Br. J. Pharmacol., 95, 830834.
  • AMEZCUA, J.L., PALMER, R.M.J., de SOUZA, B.M. & MONCADA, S. (1989). Nitric oxide synthesized from l-arginine regulates vascular tone in the coronary circulation of the rabbit. Br. J. Pharmacol., 97, 11191124.
  • DAWSON, R.M.C., ELLIOTT, D.C., ELLIOTT, W.H. & JONES, K.M. (1986). Data for Biochemical Research. pp. 404405. Oxford: Clarendon.
  • FURCHGOTT, R.F. (1990). Endothelium-derived relaxing factor: some old and new findings. In Nitric Oxide from l-Arginine: a Bioregulatory System ed. Moncada, S. & Higgs, E.A. pp. 517. Amsterdam: Elsevier.
  • GARTHWAITE, J., GARTHWAITE, G., PALMER, R.M.J. & MONCADA, S. (1989). NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol., 172, 413416.
  • GIBSON, A., SHOKOUFEH, M., HOBBS, A.J. & MOORE, P.K. (1990). l-NG-monomethylarginine and l-NG-nitroarginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br. J. Pharmacol., 99, 602606.
  • GILES, H., BOLOFO, M.L. & MARTIN, G.R. (1990). Agonist- and tissue-dependence of susceptibility of endothelium-dependent relaxations to l-NAME. Br. J. Pharmacol., 100, 452P.
  • GILLESPIE, J.S., LIU, X. & MARTIN, W. (1989). The effects of l-arginine and NG-monomethyl l-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. Br. J. Pharmacol., 98, 10801082.
  • IGNARRO, L.J., BUGA, G.M., WOOD, K.S., BYRNS, R.E. & CHAUDHURI, G. (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci., U.S.A., 84, 92659269.
  • KELM, M. & SCHRADER, J. (1988). Nitric oxide release from the isolated guinea pig heart. Eur. J. Pharmacol., 155, 313316.
  • KNOWLES, R.G., PALACIOS, M., PALMER, R.M.J. & MONCADA, S. (1989). Formation of nitric oxide from l-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci., U.S.A., 86, 51595162.
  • KNOWLES, R.G., PALACIOS, M., PALMER, R.M.J. & MONCADA, S. (1990). Kinetic characteristics of nitric oxide synthase from rat brain. Biochem. J., 269, 207210.
  • KOBAYASHI, Y. & HATTORI, K. (1990). Nitroarginine inhibits endothelium-derived relaxation. Jpn. J. Pharmacol., 52, 167169.
  • LEVI, R., GROSS, S.S., LAMPARTER, B., FASEHUN, O.A., AISAKA, K., JAFFE, E.A., GRIFFITH, O.W. & STUEHR, D.J. (1990). Evidence that l-arginine is the biosynthetic precursor of vascular and cardiac nitric oxide. In Nitric Oxide from l-Arginine: a Bioregulatory System. ed. Moncada, S. & Higgs, E.A. pp. 3545. Amsterdam: Elsevier.
  • McCALL, T. PALMER, R.M.J., BOUGHTON-SMITH, N., WHITTLE, B.J.R. & MONCADA, S. (1990). The l-arginine:nitric oxide pathway in neutrophils. In Nitric Oxide from l-Arginine: a Bioregulatory System. ed. Moncada, S. & Higgs, E.A. pp. 257265. Amsterdam: Elsevier.
  • MEYER, B., SCHMIDT, K., HUMBERT, R. & BOHME, E. (1989). Biosynthesis of endothelium-derived relaxing factor, a cytosolic enzyme in porcine aortic endothelial cells Ca2+-dependently converts l-arginine into an activator of guanylate cyclase. Biochem. Biophys. Res. Commun., 164, 678685.
  • MOORE, P.K., AL-SWAYEH, O.A., CHONG, N.W.S., EVANS, R.A. & GIBSON, A. (1990). l-NG-nitro arginine (l-NOARG) a novel, l-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br. J. Pharmacol., 99, 408412.
  • MÜLSCH, A., BASSENGE, E. & BUSSE, R. (1989). Nitric oxide synthesis in endothelial cytosol: Evidence for a calcium-dependent and a calcium-independent mechanism. Naunyn-Schmiedebergs Arch. Pharmacol., 340, 767770.
  • MÜLSCH, A. & BUSSE, R. (1990). NG-nitro-l-arginine (N5-[imino(nitro amino)methyl]-l-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from l-arginine. Naunyn-Schmiedebergs Arch. Pharmacol., 341, 143147.
  • PALACIOS, M., KNOWLES, R.G., PALMER, R.M.J. & MONCADA, S. (1989). Nitric oxide from l-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem. Biophys. Res. Commun., 165, 802809.
  • PALMER, R.M.J. & MONCADA, S. (1989). A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun., 158, 348352.
  • PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524526.
  • PALMER, R.M.J., ASHTON, D.S. & MONCADA, S. (1988a). Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature, 333, 664666.
  • PALMER, R.M.J., REES, D.D., ASHTON, D.S. & MONCADA, S. (1988b). l-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 153, 12511256.
  • PATTHY, A., BAJUSZ, S. & PATTHY, L. (1977). Preparation and characterisation of NG-mono-di- and trimethylated arginines. Acta. Biochim. Biophys. Acad. Sci. Hung., 12, 191196.
  • RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1987a). Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol., 92, 181187.
  • RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1987b). The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol., 92, 639646.
  • RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1990). Characterisation of the l-arginine:nitric oxide pathway in human platelets. Br. J. Pharmacol. (in press).
  • REES, D.D., PALMER, R.M.J., HODSON, H.F. & MONCADA, S. (1989a). A specific inhibitor of nitric oxide formation from l-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol., 96, 418424.
  • REES, D.D., PALMER, R.M.J. & MONCADA, S. (1989b). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A., 86, 33753378.
  • SAKUMA, I., STUEHR, D.J., GROSS, S.S., NATHAN, C. & LEVI, R. (1988). Identification of arginine as a precursor of endothelium-derived relaxing factor (EDRF). Proc. Natl. Acad. Sci., U.S.A., 85, 86648667.
  • SCANNELL, J.P., AX, H.A., PRUESS, D.L., WILLIAMS, T., DEMNY, T.C. & STEMPEL, A. (1972). Antimetabolites produced by microorganisms. VI. L-N-(1-iminoethyl) ornithine. J. Antibiot., 25, 179184.
  • VALLANCE, P., COLLIER, J. & MONCADA, S. (1989a). Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet, ii, 9971000.
  • VALLANCE, P., COLLIER, J. & MONCADA, S. (1989b). Nitric oxide synthesised from l-arginine mediates endothelium-dependent dilatation in human veins. Cardiovasc. Res., 23, 10531057.